Compare EQH & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EQH | ALGN |
|---|---|---|
| Founded | 1859 | 1997 |
| Country | United States | United States |
| Employees | 8000 | N/A |
| Industry | Specialty Insurers | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 12.4B |
| IPO Year | N/A | 2000 |
| Metric | EQH | ALGN |
|---|---|---|
| Price | $41.36 | $191.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $56.91 | ★ $198.09 |
| AVG Volume (30 Days) | ★ 4.7M | 825.4K |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.60% | N/A |
| EPS Growth | N/A | ★ 0.53 |
| EPS | N/A | ★ 5.65 |
| Revenue | N/A | ★ $387,126,000.00 |
| Revenue This Year | $43.13 | $5.78 |
| Revenue Next Year | $7.45 | $4.62 |
| P/E Ratio | ★ N/A | $34.65 |
| Revenue Growth | N/A | ★ 23.95 |
| 52 Week Low | $35.20 | $122.00 |
| 52 Week High | $56.61 | $208.31 |
| Indicator | EQH | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 58.89 | 60.82 |
| Support Level | $36.49 | $129.10 |
| Resistance Level | $49.44 | $199.06 |
| Average True Range (ATR) | 1.40 | 6.19 |
| MACD | 0.45 | 2.05 |
| Stochastic Oscillator | 69.35 | 75.04 |
Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.